Skip to main content
Erschienen in: Clinical Rheumatology 3/2006

01.05.2006 | Original Article

Serum lipid profile in fibromyalgia women

verfasst von: Gulcan Gurer, Omer Faruk Sendur, Cavidan Ay

Erschienen in: Clinical Rheumatology | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

The etiology and pathogenic mechanisms of fibromyalgia (FM) syndrome are unknown. A number of studies have shown that there is an association between some of the musculoskeletal system diseases and hyperlipidemia. The aims of this study were (1) to compare the serum lipid profile among FM and healthy women and (2) to investigate the relationship between serum lipid levels and FM findings. One hundred sixty-four women (82 women with FM as study group and 82 healthy women as control group) were enrolled in the study. The mean serum total cholesterol and low-density lipoprotein cholesterol (LDL-c) were found significantly higher in the FM group than that in the control group (p<0.05). However, There was no statistically significant difference in the mean serum triglyceride, high-density lipoprotein cholesterol (HDL-c), and very low-density lipoprotein cholesterol (VLDL-c) values between the two groups (p>0.05). In the FM group, we could not find a significant correlation between the serum lipid profile values and the FM parameters (p>0.05).
Literatur
1.
Zurück zum Zitat Bernatsky S, Dobkin PL, De Civita M, Penrod JR (2005) Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly 135:76–81PubMed Bernatsky S, Dobkin PL, De Civita M, Penrod JR (2005) Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly 135:76–81PubMed
2.
Zurück zum Zitat McCarberg B, Barkin RL, Wright JA, Cronan TA, Groessl E, Schmidt SM (2003) Tender points as predictors of distress and the pharmacologic management of fibromyalgia syndrome. Am J Ther 10:176–192CrossRefPubMed McCarberg B, Barkin RL, Wright JA, Cronan TA, Groessl E, Schmidt SM (2003) Tender points as predictors of distress and the pharmacologic management of fibromyalgia syndrome. Am J Ther 10:176–192CrossRefPubMed
3.
Zurück zum Zitat Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMedCrossRef Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMedCrossRef
4.
Zurück zum Zitat White KP, Speechley M, Harth M, Ostbye T (1999) The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26:1570–1576PubMed White KP, Speechley M, Harth M, Ostbye T (1999) The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26:1570–1576PubMed
5.
Zurück zum Zitat Alarcon GS, Bradley LA (1998) Advances in the treatment of fibromyalgia: current status and future directions. Am J Med Sci 315:397–404CrossRefPubMed Alarcon GS, Bradley LA (1998) Advances in the treatment of fibromyalgia: current status and future directions. Am J Med Sci 315:397–404CrossRefPubMed
6.
Zurück zum Zitat Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ, Hewett JE, Johnson JC (1999) A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 21:180–191PubMedCrossRef Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ, Hewett JE, Johnson JC (1999) A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 21:180–191PubMedCrossRef
7.
Zurück zum Zitat Thomas E, Blotman F (2002) Are antidepressants effective in fibromyalgia? Joint Bone Spine 69:531–533CrossRefPubMed Thomas E, Blotman F (2002) Are antidepressants effective in fibromyalgia? Joint Bone Spine 69:531–533CrossRefPubMed
8.
Zurück zum Zitat Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL (2004) Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis 63:290–296CrossRefPubMed Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL (2004) Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis 63:290–296CrossRefPubMed
9.
Zurück zum Zitat Klemp P, Halland AM, Majoos FL, Steyn K (1993) Musculoskeletal manifestations in hyperlipidemia: a controlled study. Ann Rheum Dis 52:44–48PubMed Klemp P, Halland AM, Majoos FL, Steyn K (1993) Musculoskeletal manifestations in hyperlipidemia: a controlled study. Ann Rheum Dis 52:44–48PubMed
10.
Zurück zum Zitat Careless DJ, Cohen MG (1993) Rheumatic manifestations of hyperlipidemia and antihyperlipidemia drug therapy. Semin Arthritis Rheum 23:90–98PubMedCrossRef Careless DJ, Cohen MG (1993) Rheumatic manifestations of hyperlipidemia and antihyperlipidemia drug therapy. Semin Arthritis Rheum 23:90–98PubMedCrossRef
11.
Zurück zum Zitat Struthers GR, Scott DL, Bacon PA, Walton KW (1983) Musculoskeletal disorders in patients with hyperlipidemia. Ann Rheum Dis 42:519–523PubMed Struthers GR, Scott DL, Bacon PA, Walton KW (1983) Musculoskeletal disorders in patients with hyperlipidemia. Ann Rheum Dis 42:519–523PubMed
12.
Zurück zum Zitat Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef
13.
Zurück zum Zitat Burkhardt CS, Clark SR, Bennett RM (1991) The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728–733PubMed Burkhardt CS, Clark SR, Bennett RM (1991) The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728–733PubMed
14.
Zurück zum Zitat Hedin PJ, Hamme M, Burkhardt CS, Engstrom-Laurent A (1995) The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol 24:69–75PubMedCrossRef Hedin PJ, Hamme M, Burkhardt CS, Engstrom-Laurent A (1995) The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol 24:69–75PubMedCrossRef
15.
Zurück zum Zitat Buskila D, Neumann L (1996) Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the Fibromyalgia Impact Questionnaire. J Rheumatol 23:903–906PubMed Buskila D, Neumann L (1996) Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the Fibromyalgia Impact Questionnaire. J Rheumatol 23:903–906PubMed
16.
Zurück zum Zitat Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 27:1984–1988PubMed Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 27:1984–1988PubMed
17.
Zurück zum Zitat Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12CrossRefPubMed Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12CrossRefPubMed
18.
Zurück zum Zitat Ozgocmen S, Ardicoglu O (2000) Lipid profile in patients with fibromyalgia and myofascial pain syndromes. Yonsei Med J 41:541–545PubMed Ozgocmen S, Ardicoglu O (2000) Lipid profile in patients with fibromyalgia and myofascial pain syndromes. Yonsei Med J 41:541–545PubMed
19.
Zurück zum Zitat Hacettepe University Institute of Population Studies (2004), General Directorate of Mother and Child Health/Family Planning. Ministry of Health, Ankara, Turkey, p 65 Hacettepe University Institute of Population Studies (2004), General Directorate of Mother and Child Health/Family Planning. Ministry of Health, Ankara, Turkey, p 65
20.
Zurück zum Zitat Keel P (1999) Pain management strategies and team approach. Baillieres Best Pract Res Clin Rheumatol 13:493–506CrossRefPubMed Keel P (1999) Pain management strategies and team approach. Baillieres Best Pract Res Clin Rheumatol 13:493–506CrossRefPubMed
21.
Zurück zum Zitat Sim J, Adams N (1999) Physical and other non-pharmacological interventions for fibromyalgia. Baillieres Best Pract Res Clin Rheumatol 13:507–523CrossRefPubMed Sim J, Adams N (1999) Physical and other non-pharmacological interventions for fibromyalgia. Baillieres Best Pract Res Clin Rheumatol 13:507–523CrossRefPubMed
22.
Zurück zum Zitat Oliver K, Cronan T (2002) Predictors of exercise behaviors among fibromyalgia patients. Prev Med 35:383–389PubMedCrossRef Oliver K, Cronan T (2002) Predictors of exercise behaviors among fibromyalgia patients. Prev Med 35:383–389PubMedCrossRef
23.
Zurück zum Zitat Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafede RP, Porter J, Specht D (1989) Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 32:454–460PubMedCrossRef Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafede RP, Porter J, Specht D (1989) Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 32:454–460PubMedCrossRef
24.
Zurück zum Zitat Aguilo A, Tauler P, Pilar Guix M, Villa G, Cordova A, Tur JA, Pons A (2003) Effect of exercise intensity and training on antioxidants and cholesterol profile in cyclists. J Nutr Biochem 14:319–325CrossRefPubMed Aguilo A, Tauler P, Pilar Guix M, Villa G, Cordova A, Tur JA, Pons A (2003) Effect of exercise intensity and training on antioxidants and cholesterol profile in cyclists. J Nutr Biochem 14:319–325CrossRefPubMed
25.
Zurück zum Zitat Hardman AE (1996) Exercise in the prevention of atherosclerotic, metabolic and hypertensive diseases: a review. J Sports Sci 14:201–218CrossRefPubMed Hardman AE (1996) Exercise in the prevention of atherosclerotic, metabolic and hypertensive diseases: a review. J Sports Sci 14:201–218CrossRefPubMed
26.
Zurück zum Zitat Wood PD (1994) Physical activity, diet, and health: independent and interactive effects. Med Sci Sports Exerc 26:838–843PubMed Wood PD (1994) Physical activity, diet, and health: independent and interactive effects. Med Sci Sports Exerc 26:838–843PubMed
27.
Zurück zum Zitat Brites FD, Evelson PA, Christiansen MG, Nicol MF, Basílico MJ, Wikinski RW, Llesuy SF (1999) Soccer players under regular training show oxidative stress but an improved plasma antioxidant status. Clin Sci 96:381–385CrossRefPubMed Brites FD, Evelson PA, Christiansen MG, Nicol MF, Basílico MJ, Wikinski RW, Llesuy SF (1999) Soccer players under regular training show oxidative stress but an improved plasma antioxidant status. Clin Sci 96:381–385CrossRefPubMed
Metadaten
Titel
Serum lipid profile in fibromyalgia women
verfasst von
Gulcan Gurer
Omer Faruk Sendur
Cavidan Ay
Publikationsdatum
01.05.2006
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 3/2006
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0004-5

Weitere Artikel der Ausgabe 3/2006

Clinical Rheumatology 3/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.